Healthcare sector projects by Ajanta Pharma Limited in USA
Project Information
7087
Ajanta Pharma Limited
Ajanta Pharma has received final approval for its generic version of acute migraine pain relief drug almotriptan malate tablets from the US health regulator.
The approval by the US Food and Drug Administration (USFDA) is for multiple strengths of 6.25mg and 12.5mg of the generic version of Janssen Pharmaceuticals’ Axert tablets, Ajanta Pharma said in a BSE filing.
Ajanta Pharma USA Inc, a wholly-owned subsidiary of the company, is scheduled to launch the almotriptan malate tablets in the US shortly
Project Value
Refer document
Clearances Approved
USA
Maharashtra
India
Healthcare
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
